How cancer metabolism is tuned for proliferation and vulnerable to disruption (Q38059777)

28 August 2017

How cancer metabolism is tuned for proliferation and vulnerable to disruption (English)

1 reference

PubMed ID

23151579

Erratum: Corrigendum: How cancer metabolism is tuned for proliferation and vulnerable to disruption

28 August 2017

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NATURE11827

author

Adrian Harris

series ordinal

2

1 reference

28 August 2017

Almut Schulze

1

0 references

language of work or name

English

0 references

publication date

1 November 2012

1 reference

28 August 2017

1 reference

28 August 2017

491

1 reference

28 August 2017

364-373

1 reference

28 August 2017

7424

1 reference

https://scigraph.springernature.com/pub.10.1038/nature11706

28 August 2017

0 references

cites work

Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression

1 reference

12 December 2020

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

1 reference

12 December 2020

Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts

1 reference

12 December 2020

Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies

1 reference

12 December 2020

On the Origin of Cancer Cells

1 reference

12 December 2020

The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

1 reference

12 December 2020

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

1 reference

12 December 2020

Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models

1 reference

12 December 2020

Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma

1 reference

12 December 2020

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

1 reference

12 December 2020

SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth

1 reference

12 December 2020

Why do cancers have high aerobic glycolysis?

1 reference

12 December 2020

Dysregulation of the mevalonate pathway promotes transformation

1 reference

12 December 2020

Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis

1 reference

12 December 2020

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

1 reference

12 December 2020

Regulation of cancer cell metabolism

1 reference

12 December 2020

Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality

1 reference

12 December 2020

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

1 reference

12 December 2020

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

1 reference

12 December 2020

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

1 reference

12 December 2020

Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling

1 reference

12 December 2020

IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics

1 reference

12 December 2020

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

1 reference

12 December 2020

Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.

1 reference

12 December 2020

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

1 reference

12 December 2020

CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors

1 reference

12 December 2020

Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review

1 reference

12 December 2020

An integrated genomic analysis of human glioblastoma multiforme

1 reference

12 December 2020

Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

1 reference

12 December 2020

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

1 reference

12 December 2020

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

1 reference

12 December 2020

Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses

1 reference

12 December 2020

Global reconstruction of the human metabolic network based on genomic and bibliomic data

1 reference

12 December 2020

Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability

1 reference

12 December 2020

Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence

1 reference

12 December 2020

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

1 reference

12 December 2020

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

1 reference

12 December 2020

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

1 reference

12 December 2020

Targeting cancer metabolism: a therapeutic window opens

1 reference

12 December 2020

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

12 December 2020

Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas

1 reference

12 December 2020

Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo

1 reference

12 December 2020

Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells

1 reference

12 December 2020

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

1 reference

12 December 2020

Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors

1 reference

12 December 2020

Recurring mutations found by sequencing an acute myeloid leukemia genome

1 reference

12 December 2020

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

1 reference

12 December 2020

Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase

1 reference

12 December 2020

Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target

1 reference

12 December 2020

Lipid metabolism in cancer

1 reference

12 December 2020

Activation of a metabolic gene regulatory network downstream of mTOR complex 1

1 reference

12 December 2020

Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation.

1 reference

12 December 2020

TIGAR, a p53-inducible regulator of glycolysis and apoptosis

1 reference

12 December 2020

Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers

1 reference

12 December 2020

Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway

1 reference

12 December 2020

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

1 reference

12 December 2020

Pyruvate kinase M2 is a phosphotyrosine-binding protein

1 reference

12 December 2020

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

1 reference

12 December 2020

The monocarboxylate transporter family--role and regulation

1 reference

12 December 2020

ATP-citrate lyase links cellular metabolism to histone acetylation

1 reference

12 December 2020

Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis

1 reference

12 December 2020

C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight

1 reference

12 December 2020

Hypoxia, HIF1 and glucose metabolism in the solid tumour

1 reference

12 December 2020

Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation.

1 reference

12 December 2020

IDH1 and IDH2 mutations in gliomas

1 reference

12 December 2020

Reductive carboxylation supports growth in tumour cells with defective mitochondria.

1 reference

12 December 2020

Mitochondrial reactive oxygen species regulate hypoxic signaling

1 reference

12 December 2020

FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression

1 reference

12 December 2020

Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells

1 reference

12 December 2020

13C MRS studies of neuroenergetics and neurotransmitter cycling in humans

1 reference

12 December 2020

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

1 reference

12 December 2020

Mitochondrial tumour suppressors: a genetic and biochemical update

1 reference

12 December 2020

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

1 reference

12 December 2020

p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase

1 reference

12 December 2020

SnapShot: Tumor angiogenesis

1 reference

12 December 2020

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

1 reference

12 December 2020

Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer

1 reference

12 December 2020

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

1 reference

12 December 2020

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

1 reference

12 December 2020

IDH mutation impairs histone demethylation and results in a block to cell differentiation

1 reference

12 December 2020

Understanding the Warburg effect: the metabolic requirements of cell proliferation

1 reference

12 December 2020

Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.

1 reference

12 December 2020

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

1 reference

12 December 2020

Metabolic modulation of glioblastoma with dichloroacetate

1 reference

12 December 2020

p53 regulates mitochondrial respiration

1 reference

12 December 2020

HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer

1 reference

12 December 2020

Aerobic glycolysis: meeting the metabolic requirements of cell proliferation

1 reference

12 December 2020

Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

1 reference

12 December 2020

Normal and cancer cell metabolism: lymphocytes and lymphoma.

1 reference

12 December 2020

Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.

1 reference

12 December 2020

Deregulated MYC expression induces dependence upon AMPK-related kinase 5.

1 reference

12 December 2020

New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation

1 reference

12 December 2020

Predicting selective drug targets in cancer through metabolic networks.

1 reference

12 December 2020

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

1 reference

12 December 2020

Current and potential applications of clinical 13C MR spectroscopy

1 reference

12 December 2020

Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia

1 reference

12 December 2020

HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition

1 reference

12 December 2020

Targeting metabolic transformation for cancer therapy.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NATURE11706

1 reference

PubMed ID

23151579

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23151579